1. sueellen
2. pitlove65965
3. BioElectrics007
4. AaronFrasier
5. rushphile7996
1.AaronFrasier 10/01/2017
Not sure. There's 25-45 million people in the United States that have IBS. I would say $20+- if it's a positive result. Hopeful...
2.AaronFrasier 10/01/2017
Oct 3rd - Announcing Results
3.pitlove65965 10/02/2017
AH looking good
4.pitlove65965 01/26/2018
nice surprise today
5.sueellen 01/26/2018
Nomura Instinet initiates as a buy, $18PT
6.rushphile7996 01/26/2018
on fire
7.keiththewolf94 07/24/2018
RedHill Biopharma Enrolls 400th Patient in Confirmatory Phase III Study with TALICIA® for H. pylori Infection
8.BioElectrics007 01/26/2018
Heading back to Nov prices
9.sueellen 10/02/2017
Ready to look ahead to Rizaport NDA and FDA guidance for ph3 Bekinda (Oct), then confirmatory 105 and Crohne's ph3 data in 8 months! Biotechs are on fire
10.DontGiveMeLip 10/01/2017
{Link} IBS affects between 25-45 million people in the United States. About 2 in 3 IBS are female. I would say $20 to the upside if positive results. {Image}
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW